Utilization of adjuvant chemotherapy in "ideal candidates" with stage III colon cancer.

被引：0
|
作者：
Soleja, Mohsin
Goksu, Suleyman Yasin
Sanford, Nina Niu
Beg, Muhammad Shaalan
Kainthla, Radhika
Sanjeevaiah, Aravind
Jones, Amy Little
Farkas, Linda
Verma, Udit
Hsieh, David
Kazmi, Syed Mohammad Ali
机构：
[1] UT Southwestern Med Ctr, Dallas, TX USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[3] Alaska Native Med Ctr, Anchorage, AK USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] UT Southwestern, Dallas, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4103
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Duration of Adjuvant Chemotherapy for Stage III Colon Cancer REPLY
    Shi, Qian
    Paul, James
    Grothey, Axel
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (04): : 396 - 397
  • [22] Refining the role of adjuvant chemotherapy in stage III colon cancer
    Tanis, Pieter J.
    COLORECTAL DISEASE, 2019, 21 (02) : 135 - 136
  • [23] ADJUVANT CHEMOTHERAPY IN HIGH-RISK STAGE II COLON CANCER.
    Lightner, A.
    Glyn, T.
    Parker, M.
    Tse, C.
    Abdelsattar, Z.
    Larson, D.
    Mathis, K.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E293 - E293
  • [24] ADJUVANT CHEMOTHERAPY IMPROVES SURVIVAL IN PATIENTS WITH STAGE II COLON CANCER.
    Mckenzie, S.
    Mailey, B.
    Artinyan, A.
    Pigazzi, A.
    Garcia-Aguilar, J.
    Kim, J.
    DISEASES OF THE COLON & RECTUM, 2010, 53 (04) : 615 - 615
  • [25] FACTORS ASSOCIATED WITH RECEIPT OF ADJUVANT CHEMOTHERAPY IN STAGE II COLON CANCER.
    Ginesi, M.
    Bliggenstorfer, J.
    Mugayo, D.
    Xu, S.
    Jodeh, D.
    Selfridge, J. E.
    Stein, S. L.
    Steinhagen, E.
    DISEASES OF THE COLON & RECTUM, 2022, 65 (05) : 35 - 36
  • [26] Impact of adjuvant chemotherapy on recurrence risk in stage II colon cancer.
    Adesoye, Taiwo
    Hu, Chung-Yuan
    Cuddy, Amanda
    Francescatti, Amanda B.
    Schumacher, Jessica R.
    You, Y. Nancy
    Van Loon, Katherine
    Schrag, Deborah
    McKellar, Daniel P.
    Winchester, David Porter
    Chang, George J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [27] Real-world survival outcomes associated with completion of adjuvant chemotherapy for stage III colon cancer.
    Boyle, Jemma Megan
    Kuryba, Angela
    Cowling, Thomas E.
    van der Meulen, Jan
    Fearnhead, Nicola S.
    Walker, Kate
    Braun, Michael
    Aggarwal, Ajay
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [28] DETERMINING THE OPTIMAL TIMING FOR INITIATION OF ADJUVANT CHEMOTHERAPY AFTER RESECTION FOR STAGE II/III COLON CANCER.
    Sun, Z.
    Adam, M. Abdelgadir
    Kim, J.
    Nussbaum, D.
    Benrashid, E.
    Mantyh, C.
    Migaly, J.
    DISEASES OF THE COLON & RECTUM, 2015, 58 (05) : E103 - E103
  • [29] Preference values associated with stage III colon cancer and adjuvant chemotherapy
    Jennie H. Best
    Louis P. Garrison
    William Hollingworth
    Scott D. Ramsey
    David L. Veenstra
    Quality of Life Research, 2010, 19 : 391 - 400
  • [30] Is it deleterious to delay the start of adjuvant chemotherapy in colon cancer stage III?
    Berglund, A.
    Cedermark, B.
    Glimelius, B.
    ANNALS OF ONCOLOGY, 2008, 19 (02) : 400 - 402
12345